Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Ratios

vs
industry
vs
history
PE Ratio 23.45
IYH's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 23.45 )
Ranked among companies with meaningful PE Ratio only.
IYH' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 23.53
Current: 23.45
0
23.53
PE Ratio without NRI 23.45
IYH's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 23.45 )
Ranked among companies with meaningful PE Ratio without NRI only.
IYH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 23.53
Current: 23.45
0
23.53
PB Ratio 3.76
IYH's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 3.76 )
Ranked among companies with meaningful PB Ratio only.
IYH' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.77
Current: 3.76
0
3.77

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.22
IYH's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 1.22 )
Ranked among companies with meaningful Dividend Yield % only.
IYH' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.24
Current: 1.22
0
1.24
5-Year Yield-on-Cost % 1.22
IYH's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 1.22 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IYH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.24
Current: 1.22
0
1.24

More Statistics

Short Percentage of Float0.00%
52-Week Range $137.39 - 160.18
Shares Outstanding (Mil)11,750,000.00
» More Articles for IYH

Headlines

Articles On GuruFocus.com
Southern First Bancshares, Inc. Announces Pricing of Public Offering of Common Stock Apr 27 2017 
BlackStar Enterprise Group, Inc., SEC Reporting Company, Announces Successful Up-Listing to OTCQB Ma Apr 27 2017 
Edwards Lifesciences To Present At The Deutsche Bank 42nd Annual Health Care Conference Apr 27 2017 
Synopsys Advances Virtual Simulation of Adaptive Headlights Apr 27 2017 
Fineqia Receives Approval as Appointed Representative of UK FCA Regulated Firm Apr 27 2017 
Upland Software to Release First Quarter Financial Results on May 11, 2017 Apr 27 2017 
RE/MAX Agents Are Most Productive in Annual REAL Trends 500 Survey Apr 27 2017 
The VWR Foundation Approves Grants to Enable Science Education Apr 27 2017 
Justice For All With Your Wonder Woman Ultimate Ticket at Regal Apr 27 2017 
Amaya Pays Additional $75 Million on Rational Group Deferred Purchase Price Apr 27 2017 

More From Other Websites
General Electric’s Healthcare Revenue Rose in 1Q17 Apr 27 2017
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? Apr 24 2017
Eli Lilly’s Cialis and Other Cardiovascular Products in 1Q17 Apr 24 2017
Will New Products Help Eli Lilly in 1Q17? Apr 20 2017
Johnson & Johnson’s 1Q17 Earnings Miss Revenue Estimates Apr 20 2017
Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
5 ETFs to Buy If You Love Johnson & Johnson's First-Quarter Earnings Apr 17 2017
How Bristol-Myers Squibb Stock Performed in 1Q17 Apr 07 2017
What Wall Street Analysts Recommend for Pfizer Apr 05 2017
There's Value in Healthcare ETFs Apr 04 2017
Eli Lilly’s Valuation Compared to Its Peers’ Mar 29 2017
Healthcare Stocks Await TrumpCare Vote Mar 23 2017
A Look at Ionis Pharmaceuticals’ Spinraza Mar 22 2017
Trump, Biogen and Amgen Hammer Healthcare ETFs Mar 20 2017
How BMY’s Neuroscience, Immunoscience Segments Performed in 2016 Mar 20 2017
Pfizer’s Cash Flow Stamina versus Merck’s Ambitious R&D Mar 15 2017
3 Index Funds to Buy in March Mar 14 2017
Johnson & Johnson’s Medical Devices Segment Mar 14 2017
Trump finally builds a wall — though it’s not along the Mexican border Mar 09 2017
GOP Health Plan: Winners, Losers & Who Knows Mar 09 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK